Clinical Trial

Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the reduction of emotional burden (measured by Relative Stress Scale-RSS) of caregivers of migraine patients with Depressive Symptoms after 6 months after the first injection of fremanezumab.
Trial Details
NCT Number NCT07029126
Lead Sponsor Fondazione Policlinico Universitario Campus Bio-Medico
Collaborators: Teva Pharmaceuticals USA
Conditions Migraine
Enrollment 300 participants
Start Date 2024-10-03
Primary Completion 2025-10-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-19